Are We Too Risk Averse in Clinical Research?
Guest: Ken Getz, Executive Director and Research Professor, Tufts Center for the Study of Drug DevelopmentThis week, Richard Young speaks to Ken Getz, executive director and research professor at Tufts Center for the Study of Drug Development. In this episode, Richard and Ken debate whether clinical research is striking the right balance in its approach to risk and innovation, the problem-solving role played by sites, and CISCRP’s work to improve public trust in scientific advances.